A novel indicator of all-cause mortality in acute coronary syndrome: the CALLY index
- 24 March 2025
- journal article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 19 (8) , 287-294
Abstract
This study aimed to identify the prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index for predicting all-cause mortality in acute coronary syndrome (ACS) patients who have undergone primary percutaneous coronary intervention (pPCI) for revascularization. 505 patients who presented with ACS and underwent pPCI were retrospectively included in this single center study. CALLY index and other five prognostic scores were calculated. The median follow-up was 40 months. All-cause mortality was defined as the primary endpoint. The median age of the patients was 59 years, 23.4% were female. The CALLY index was categorized into low (p = 0.038), concomitant atrial fibrillation (p = 0.023), previous CABG (p = 0.001), ACE-I/ARB/ARNI use (p = 0.015), diuretic use (p = 0.021), and a low-CALLY index (p < 0.001) were identified as independent predictors of all-cause mortality in multivariate cox regression analysis. When compared to other prognostic scores according to AUC in ROC analysis, the CALLY index demonstrated the best ability to predict all-cause mortality. Additionally, patients with a high-CALLY index exhibited significantly better survival outcomes compared to those with a low-CALLY index (log-rank:p < 0.001). CALLY index can be utilized as a novel prognostic score for predicting all-cause mortality in ACS patients who have undergone pPCI.Keywords
This publication has 48 references indexed in Scilit:
- Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarctionInternational Immunopharmacology, 2024
- C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderlyClinical Nutrition ESPEN, 2024
- Low serum albumin: A neglected predictor in patients with cardiovascular diseaseEuropean Journal of Internal Medicine, 2022
- Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinomaHPB, 2022
- Hypoalbuminemia: Pathogenesis and Clinical SignificanceJournal of Parenteral and Enteral Nutrition, 2018
- A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional indexNutrition, Metabolism and Cardiovascular Diseases, 2017
- Adaptive Immunity Dysregulation in Acute Coronary SyndromesJACC, 2016
- Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventionsCardiovascular Revascularization Medicine, 2016
- Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial InfarctionJACC, 2014
- Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndromeAtherosclerosis, 2011